Safety and Efficacy of Autologous Bone-Marrow-Derived Mesenchymal Stem Cells for Treating Partial Rotator Cuff Tears: Observational Study with 4-Year Follow-Up
Open Access
- 6 February 2026
- journal article
- research article
- Published by MDPI AG in Biomedicines
- Vol. 14 (2) , 382
Abstract
Background/Objectives: Rotator cuff tears (RCTs) are a leading cause of shoulder pain and disability. Management typically involves conservative measures, such as physical therapy and anti-inflammatory medications, or surgery for full-thickness or refractory tears. Regenerative medicine therapies, including platelet-rich plasma (PRP), platelet lysate (PL), and mesenchymal stem cells (MSCs), show promise as alternative treatment strategies, although long-term outcomes remain under investigation. Methods: This cohort included 30 patients with partial rotator cuff tears and were treated with culture-expanded MSC injections. There was no control group. Inclusion criteria included an imaging-confirmed diagnosis of partial-thickness rotator cuff tears. Outcomes were assessed at multiple time points up to 6 years. Pain and function were assessed using the Disabilities of the Arm, Shoulder, and Hand (DASH), a Numeric Rating Scale (NRS), and the modified Single Assessment Numeric Evaluation (SANE). Results: Thirty patients (37 shoulders) were included in the analysis. Significant improvements in the NRS and DASH scores were observed at 3, 6, 12, 18, and 24 months (p < 0.01). Twenty-four months post-treatment, the mean NRS and DASH decreased by 2.25 and 15.93 points, respectively, and SANE improved by 60%. At six years, among seven respondents, the mean SANE improvement was 75.54%. During this study, no significant adverse events were reported. Conclusions: This study provides the longest known follow-up of MSC therapy for partial-thickness RCTs, finding sustained pain and functional improvements. The findings support further research into MSC-based and combination regenerative therapies as a viable alternative treatment option for partial-thickness rotator cuff tears.Keywords
This publication has 47 references indexed in Scilit:
- Bone Marrow Aspirate Concentrate May Improve Healing and Function in Rotator Cuff Repair: A Systematic ReviewArthroscopy, 2024
- Re-tears after rotator cuff repair: Current concepts reviewJournal of Clinical Orthopaedics and Trauma, 2021
- Intratendinous Injection of Mesenchymal Stem Cells for the Treatment of Rotator Cuff Disease: A 2‐Year Follow‐Up StudyArthroscopy, 2019
- Tendon explant cultures to study the communication between adipose stem cells and native tendon nicheJournal of Cellular Biochemistry, 2017
- Crosstalk between adipose stem cells and tendon cells reveals a temporal regulation of tenogenesis by matrix deposition and remodelingJournal of Cellular Physiology, 2017
- Tear progression of symptomatic full-thickness and partial-thickness rotator cuff tears as measured by repeated MRIKnee Surgery, Sports Traumatology, Arthroscopy, 2016
- Reduced levels of mesenchymal stem cells at the tendon–bone interface tuberosity in patients with symptomatic rotator cuff tearInternational Orthopaedics, 2015
- Biologic augmentation of rotator cuff repair with mesenchymal stem cells during arthroscopy improves healing and prevents further tears: a case-controlled studyInternational Orthopaedics, 2014
- Epidemiology, Natural History, and Indications for Treatment of Rotator Cuff TearsClinics in Sports Medicine, 2012
- Conventional rotator cuff repair complemented by the aid of mononuclear autologous stem cellsKnee Surgery, Sports Traumatology, Arthroscopy, 2011